Efficacy and Safety of Tocilizumab
Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (Clinical trial)
Did you know, that you can look up clinical trials on scleroderma on following sites:
For instance you can find following trial by Genentech:
A Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc) [focuSSced]
Official title: A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Tocilizumab Versus Placebo in Patients With Systemic Sclerosis.
The company is looking to enroll 210 patients in the following countries: Argentina, Belgium, Brazil, Bulgaria, Canada, Croatia, Denmark, France, Germany, Greece, Hungary, Italy, Lithuania, Japan, Mexico, Netherlands, Poland, Portugal, Romania, South Africa, Spain, Switzerland, UK, and USA.
news & events
Annelise, a Danish scleroderma patient for many years talks about the patient’s journey towards a diagnosis.
Meet António Pereira who has lived with and fought against Scleroderma for 40 years.
Meet Tânia Vieira who talks about the biggest passion many mothers can relate to.